Resultado de búsqueda
Hace 3 días · Updated: 2023-04-19. Print. Mail. Large Medium Small. The establishment of Tiankai Higher Education Innovation Park was an important and strategic decision made by Tianjin to fully implement the strategy for invigorating synergy between science and education and promoting development via innovation.
Hace 4 días · Tianjin is actively nurturing and leveraging the role of startup and industrial funds such as the Haihe Industry Fund, Tianjin University Andon Hibiscus Fund and Nankai Xinkai Lake Fund to attract market-oriented technology service businesses in fields such as technology and commercial verification and pilot testing.
Hace 2 días · Tianjin is expected to gather pace amid its push for higher-level innovation, supported by the launch of the Tiankai Higher Education Innovation Park, an incubation hub and high-tech industrial park, in the North China municipality, officials of local universities said.
Hace 6 días · Tianjin University and Nankai University are set to jointly inaugurate a high-tech business startup park in Tianjin on Thursday to encourage students to become enterpreneurs. The Tiankai Higher Education Innovation Park — with three in Tianjin — is envisioned as an international-level industrial startup park and has attracted ...
16 de may. de 2024 · 2024-05-16. The first “China Collegiate Computing Contest - AIGC Innovation Competition”, sponsored by the Computer Education Research Association of Chinese Universities and jointly organized by...
Hace 4 días · The 2024 International Symposium on Electrocatalysis and Electrosynthesis of the Chinese Chemical Society was held in Tianjin on March 29-31. The Symposium was co-sponsored by the Electrochemistry Committee of the Chinese Chemical Society and Nankai University, and organized by the eScience Editorial Office, the State Key Laboratory of Advanced Chemical Power Sources, the Key Laboratory of ...
13 de may. de 2024 · 2024-05-13. On March 25th, CP0119 tablets, a class-1 new chemical drug independently developed by a team from the College of Pharmacy of Nankai University, received the Notice of Approval for Drug Clinical Trials issued by the National Medical Products Administration, which granted approval for clinical trials to treat slow transit constipation.
